Short-Term Effect of Vitamin K Administration on Prednisolone-Induced Loss of Bone Mineral Density in Patients with Chronic Glomerulonephritis
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Glucocorticoid-induced osteoporosis has been reported to be caused by enhanced bone resorption and suppressed bone formation. To clarify whether administration of vitamin K, which enhances bone formation, prevents prednisolone-induced loss of bone mineral density (BMD), a randomized, prospective, controlled study was conducted on 20 patients with chronic glomerulonephritis scheduled for treatment with prednisolone. All patients were initially treated with 0.8 mg/kg body weight/day of prednisolone (maximum of 40 mg) for 4 weeks, tapering to 20 mg/day over approximately 6 weeks. Ten patients received prednisolone alone (Group 1), and the other 10 patients received prednisolone plus 15 mg of menatetrenone, vitamin K, three times per day (Group 2). BMD of the lumbar spine measured by dual-energy X-ray absorptiometry (DXA) and biochemical markers of bone metabolism in blood and urine were evaluated before and 10 weeks after administration of prednisolone alone or with menatetrenone. In Group 1, treatment with prednisolone significantly reduced BMD of the lumbar spine from 1.14 +/- 0.12 to 1.10 +/- 0.11 g/cm2 (P = 0.0029). Serum intact osteocalcin and procollagen type I C-peptide (PICP) concentrations, biochemical markers of bone formation, were markedly reduced. A biochemical marker of bone resorption, urinary excretion of deoxypyridinoline, was significantly reduced. In Group 2, prednisolone-induced reduction of BMD was prevented by menatetrenone administration (1.09 +/- 0.09 to 1.07 +/- 0.07 g/cm2, P = 0.153). Menatetrenone prevented reduction of PICP concentration by prednisolone but not in serum intact osteocalcin concentration and urinary excretion of deoxypyridinoline. Thus, treatment with prednisolone resulted in loss of BMD of the lumbar spine associated with suppression of both bone formation and bone resorption. Menatetrenone is a useful agent in preventing prednisolone-induced loss of BMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conflicting data exist; in some studies, vitamin K antagonists demonstrate no differences in BMD or fracture rates461, while other data suggest lessening of steroid-induced BMD462 and sex-specific improvements in insulin sensitivity463.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [462]
Citations
Cites
Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin
Sambrook, P., Birmingham, J., Kelly, P., Kempler, S., Nguyen, T., Pocock, N., & Eisman, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282404 · Cited by 520 · cited 1×
“Pharmacological doses of vitamin D may cause acute renal failure secondary to hypercalcemia associated with vitamin D intoxication [17, 21].”
BackgroundHahn, T. J., Halstead, L. R., Teitelbaum, S. L., & Hahn, B. H. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109506 · Cited by 399 · cited 1×
“Bone resorption was stimulated by glucocorticoids in some studies [1, 2, 5, 6], but inhibited in others [7–9].”
ResultTestosterone Therapy in Glucocorticoid-Treated Men
Reid, I. R. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440100065008 · Cited by 365
Dempster, D. W., Arlot, M. A., & Meunier, P. J. (1983) · Calcified Tissue International · doi:10.1007/bf02405069 · Cited by 233
ELECTROCHEMICAL DETECTION OF DEPRESSED CIRCULATING LEVELS OF VITAMIN K1IN OSTEOPOROSIS
HART, J. P., SHEARER, M. J., KLENERMAN, L., CATTERALL, A., REEVE, J., SAMBROOK, P. N., DODOS, R. A., BITENSKY, L., & CHAYEN, J. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-6-1268 · Cited by 165 · cited 1×
“Circulating levels of vitamin K in osteoporotic patients are significantly lower than those in age-matched control subjects [13, 14].”
BackgroundEffect of Glucocorticoids on Bone Resorption in Tissue Culture
RAISZ, L. G., TRUMMEL, C. L., WENER, J. A., & SIMMONS, H. (1972) · Endocrinology · doi:10.1210/endo-90-4-961 · Cited by 160
Koshihara, Y., & Hoshi, K. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.3.431 · Cited by 147 · cited 1×
“Vitamin K has been reported to enhance bone formation in in vitro studies [10, 11].”
BackgroundHodges, S. J., Pilkington, M. J., Stamp, T. C. B., Catterall, A., Shearer, M. J., Bitensky, L., & Chayen, J. (1991) · Bone · doi:10.1016/8756-3282(91)90027-g · Cited by 143 · cited 1×
“Circulating levels of vitamin K in osteoporotic patients are significantly lower than those in age-matched control subjects [13, 14].”
BackgroundStruys, A., Snelder, A. A., & Mulder, H. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80154-5 · Cited by 135
BONE FORMATION IN HYPERCORTISONISM
Jowsey, J., & Riggs, B. L. (1970) · Acta Endocrinologica · doi:10.1530/acta.0.0630021 · Cited by 134 · cited 1×
“Bone resorption was stimulated by glucocorticoids in some studies [1, 2, 5, 6], but inhibited in others [7–9].”
ResultKin, K., Kushida, K., Yamazaki, K., Okamoto, S., & Inoue, T. (1991) · Calcified Tissue International · doi:10.1007/bf02565129 · Cited by 133
INHIBITION BY STEROIDS OF PARATHYROID HORMONE-INDUCED Ca45 RELEASE FROM EMBRYONIC RAT BONE IN VITRO
Stern, P. H. (1969) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28321-5 · Cited by 130
Gains in Bone Mineral Density with Resolution of Vitamin D Intoxication
Adams, J. S., & Lee, G. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-3-199708010-00004 · Cited by 112 · cited 1×
“Furthermore, resolution of vitamin D intoxication in subjects with osteoporosis has been reported to be associated with an increase in BMD [22].”
BackgroundMenatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro
Hara, K., Akiyama, Y., Tajima, T., & Shiraki, M. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080504 · Cited by 108 · cited 1×
“Menatetrenone has been reported to inhibit bone resorption stimulated by PTH or 1,25(OH) 2D3 in a mouse calvaria culture system [16].”
BackgroundVitamin K2 promotes 1?,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts
Koshihara, Y., Hoshi, K., Ishibashi, H., & Shiraki, M. (1996) · Calcified Tissue International · doi:10.1007/bf00369212 · Cited by 105
Schwartzman, M. S., & Franck, W. A. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90060-x · Cited by 95 · cited 1×
“Pharmacological doses of vitamin D may cause acute renal failure secondary to hypercalcemia associated with vitamin D intoxication [17, 21].”
BackgroundDIAMOND, T. H., McGuigan, L., Barbagallo, S., & Bryant, C. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80345-3 · Cited by 93
TOBIAS, J., & CHAMBERS, T. J. (1989) · Endocrinology · doi:10.1210/endo-125-3-1290 · Cited by 90
Gronowicz, G. A., & McCarthy, M. B. (1995) · Endocrinology · doi:10.1210/endo.136.2.7530648 · Cited by 87
Effects of menatetrenone on prednisolone-induced bone loss in rats
Hara, K., Akiyama, Y., Ohkawa, I., & Tajima, T. (1993) · Bone · doi:10.1016/8756-3282(93)90309-x · Cited by 81 · cited 1×
“Inin vivostudies, Hara et al.[12] have demonstrated in rats that menatetrenone, vitamin K, inhibits corticosteroid-induced bone loss.”
BackgroundGlucocorticoids stimulate resorption in fetal rat parietal bones in vitro
Dr. Gronowicz, G., McCarthy, M. B., & Raisz, L. G. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650051206 · Cited by 79 · cited 1×
“Bone resorption was stimulated by glucocorticoids in some studies [1, 2, 5, 6], but inhibited in others [7–9].”
ResultReid, I. R., Katz, J. M., Ibbertson, H. K., & Gray, D. H. (1986) · Calcified Tissue International · doi:10.1007/bf02556593 · Cited by 70
Cited by
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Weber, P. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00709-2 · Cited by 197
Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification
Shearer, M. J. (2000) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200011000-00004 · Cited by 183
Immunosuppressive agents for treating IgA nephropathy
Vecchio, M., Bonerba, B., Palmer, S. C., Craig, J. C., Ruospo, M., Samuels, J., Molony, D. A., Schena, F. P., & Strippoli, G. F. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003965.pub2 · Cited by 119
Emaus, N., Gjesdal, C. G., Almås, B., Christensen, M., Grimsgaard, A. S., Berntsen, G. K. R., Salomonsen, L., & Fønnebø, V. (2010) · Osteoporosis International · doi:10.1007/s00198-009-1126-4 · Cited by 102
Metadata
- Authors
- Yonemura, K., Kimura, M., Miyaji, T., & Hishida, A.
- Affiliations
- Hamamatsu University (JP)
- Shizuoka University (JP)
- ORCID
- Kimura, M.
- Venue
- Calcified Tissue International
- Published
- 2000-02
- Volume
- 66
- Issue
- 2
- Pages
- 123-128
- ISSN
- 0171-967X (ISSN-L)
- OpenAlex
- W2034789148
- Cited by
- 64
- References
- 22
- Citations by year
- 2024: 1 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 3 · 2016: 3 · 2015: 3 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Calcified Tissue International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin K Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Keywords
- vitamin K, menatetrenone, prednisolone, glucocorticoid-induced osteoporosis, bone mineral density, chronic glomerulonephritis, bone formation, bone resorption, osteocalcin, deoxypyridinoline, lumbar spine
- MeSH terms
- Adolescent, Adult, Anti-Inflammatory Agents, Calcium, Chronic Disease, Drug Therapy, Combination, Female, Glomerulonephritis, Hemostatics, Humans, Male, Middle Aged, Osteoporosis, Phosphates, Prednisolone, Vitamin K, Absorptiometry, Photon, Bone Density, Vitamin K 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.